C07D 223 - Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom

Patents for C07D 223 - Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom (8,732)
12/2011
12/14/2011	CN102276530A 7，8-二甲氧基-1，3-二氢-2h-3-苯并氮杂卓-2-酮的制备方法 7,8-dimethoxy-1,3-dihydro--2h-3- benzazepine-2-one Preparation of
12/14/2011	CN101412683B 一种2-溴-4,5-二甲氧基肉桂腈及其制备方法 One kind of 2-bromo-4,5-dimethoxy Cinnamonitrile its preparation method
12/13/2011	US8076325 1,2,4,5-tetrahydro-3H-benzazepine compounds, a process for their preparation and pharmaceutical compositions containing them
12/08/2011	WO2011153206A1 Processes for the preparation of 5-ht2c receptor agonists
12/08/2011	WO2011151436A2 Novel compounds, method for use them and pharmaceutical composition containing them
12/08/2011	US20110300116 Method for Generating a Recombinant Clonal Cell Line and Novel Reagents for Use in the Method
12/07/2011	CN102267946A 高光学纯度含手性联萘骨架的α-季碳氨基酸酯类化合物、其制备方法及用途 Α- amino acid ester quaternary carbon-containing compound having a high optical purity of chiral binaphthyl skeleton, their preparation and use
12/07/2011	CN101263116B 可用作肝肉碱棕榈酰转移酶抑制剂的新型杂双环衍生物 Used as a liver carnitine palmitoyl transferase inhibitors novel heterobicyclic derivatives
12/07/2011	CN101084193B (r)-8-氯-1-甲基-2,3,4,5-四氢-1h-3-苯并氮杂卓盐酸盐的晶型 (R) -8- chloro-l-methyl-2,3,4,5-tetrahydro -1h-3- benzazepine hydrochloride crystalline form of
12/01/2011	US20110294999 Process for the synthesis of ivabradine and addition salts thereof with a pharmaceutically acceptable acid
12/01/2011	US20110294785 Influenza a virus inhibition
11/2011
11/30/2011	EP2010289B1 Benzoazepin-oxy-acetic acid derivatives as ppar-delta agonists used for the increase of hdl-c, lower ldl-c and lower cholesterol
11/30/2011	CN102264689A 制备伊伐布雷定的方法 Ivabradine is prepared
11/30/2011	CN102260213A 一种托伐普坦的制备方法 A process for cutting Putan of care
11/29/2011	CA2541470C Substituted dibenzo-azepine and benzo-diazepine derivatives useful as gamma-secretase inhibitors
11/24/2011	US20110288076 Sphingosine-1-Phosphate Receptor Antagonists
11/24/2011	US20110288057 Salicylic acid derivatives being farnesyl pyrophosphate synthase activity inhibitors
11/23/2011	EP2388248A1 Methods for the preparation of ivabradine sulfate and form i crystal thereof
11/23/2011	CN102250005A Preparation method of Eslicarbazepine
11/23/2011	CN102250004A Preparation method of 3-[(1-(1S)-phenylethyl) amino]-2,3,4,5-tetrahydro-2-oxo-1H-(3S)-benzazepine
11/23/2011	CN101508674B Benazepine-2-ketone compound containing ethylene imine ring, preparation and application thereof
11/22/2011	US8063039 3-aminopyrrolidone derivatives
11/17/2011	US20110282053 Organic Compounds
11/17/2011	US20110281847 Selective estrogen receptor modulators for the treatment of vasomotor symptoms
11/17/2011	US20110281844 Non-imidazole alkylamines as histamine h3-receptor ligands and their therapeutic applications
11/16/2011	EP2385944A2 Fluorine containing compounds and methods of use thereof
11/16/2011	CN102245733A Novel organic electroluminescent compounds and organic electroluminescent device using the same
11/16/2011	CN101723897B Method for synthesizing Ivabradine
11/15/2011	US8058288 Amido compounds and their use as pharmaceuticals
11/10/2011	WO2011138795A2 Process for preparing (s)-10-acetoxy-10,11-dihydro-5h-dibenz[b,f] azepine-5-carboxamide
11/10/2011	WO2011138625A1 Industrial process for the synthesis of ivabradine salts
11/10/2011	US20110275615 Novel substituted amides, their preparation and use
11/10/2011	US20110275614 Methods for the preparation of ivabradine sulfate and form i crystal thereof
11/09/2011	EP2004599B1 Process for the preparation of an n-alkyl lactam with improved colour quality
11/09/2011	CN102234248A Impurity extraction method for caprolactam production
11/09/2011	CN102233277A Preparation method for catalyst containing MFI structure zeolite
11/09/2011	CN101353325B Stable Ivabradine crystal and preparation thereof
11/03/2011	WO2011137089A1 Activators of human pyruvate kinase
11/03/2011	WO2011136484A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same
11/03/2011	WO2011104723A3 Acid addition salts of ivabradine and preparation method thereof
11/03/2011	US20110269745 6-ARYLALKYLAMINO-2,3,4,5-TETRAHYDRO-1H-BENZO[d]AZEPINES AS 5-HT2C RECEPTOR AGONISTS
11/03/2011	US20110269736 1,1'-Diadamantyl carboxylic acids, medicaments containing such compounds and their use
11/02/2011	EP2383261A1 Process for the asymmetric hydrogenation of ketones
11/02/2011	CN102229553A Multistage rearrangement system and method for preparation of caprolactam from cyclohexanone oxime
11/01/2011	CA2448094C Method for preparation of 10,11-dihydro-10-hydroxy-5h-dibenz/b,f/azepine-5-carboxamide and 10,11-dihydro-10-0x0-5h-dibenz/b,f/azepine-5-carboxamide
10/2011
10/27/2011	WO2011132171A1 Nitric oxide releasing prodrugs of therapeutic agents
10/27/2011	WO2011131315A1 Process for the asymmetric transfer hydrogenation of ketones
10/27/2011	US20110263526 Nitric Oxide Releasing Prodrugs of Therapeutic Agents
10/26/2011	CN102227486A Organic electroluminscent device using electroluminescent compounds
10/26/2011	CN102227404A Ammoximation process
10/26/2011	CN101781248B Method for synthesizing N-methylhexahydroazepin-4-one hydrochloride, azelastine hydrochloride intermediate
10/20/2011	US20110257390 Ammoximation process
10/20/2011	US20110257130 Compositions and Methods for Treatment of Renin-Angiotensin Aldosterone System (RAAS)- Related Disorders
10/19/2011	EP2377846A1 Seperation of 6-Aminocapronitrile and Hexamethylenediamine from a Mixture Comprising Hexamethylenediamine, 6-Aminocapronitrile and Tetrahydroazepine
10/19/2011	EP2376495A2 Compositions of protein receptor tyrosine kinase inhibitors
10/19/2011	EP1694334B1 Tetrahydrobenzazepines and their use in the modulation of the dopamine d3 receptor
10/19/2011	CN102219741A Process for preparing benzazepine compounds or salts thereof
10/18/2011	US8039461 Physical states of a pharmaceutical drug substance
10/12/2011	EP2374804A1 Chemokine receptor binding heterocyclic compounds with enhanced efficacy
10/12/2011	EP2374798A1 Benzazepine derivatives useful as vasopressin antagonists
10/12/2011	EP2374797A1 Benzazepine derivatives useful as vasopressin antagonists
10/12/2011	EP2374796A1 8-Chloro-1-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine, its salts, solvates or hydrates and its use for the treatment of CNS disorders
10/12/2011	EP2373614A1 Ammoximation process
10/12/2011	CN1914177B Optically active quaternary ammonium salt having axial asymmetry and process for producing alpha-amino acid and derivative thereof with the same
10/12/2011	CN102216266A Method for preparing e-caprolactam from n-acyl-6-aminocaproic acid
10/12/2011	CN102212033A Method for lowering caprolactam inclusion content in ammonium sulfate crystals
10/06/2011	US20110245493 Delivery of drug amines through an inhalation route
10/06/2011	US20110245444 Transformation of biomass
10/06/2011	US20110243960 Methods and compositions for treating p. acnes
10/05/2011	EP2371366A1 Heterocyclo inhibitors of potassium channel function
10/05/2011	CN101142178B Improved method for making caprolactam from impure 6-aminocapronitrile
09/2011
09/29/2011	WO2011117885A1 Process for preparation of enantiomers of licarbazepine
09/28/2011	EP2367782A1 Process for preparation of ivabradine
09/28/2011	CN102203213A Novel organic electroluminescent compounds and organic electroluminescent device using the same
09/27/2011	CA2440630C Metalloproteinase inhibitors
09/27/2011	CA2415847C Aminoalkylbenzoyl-benzofuran or benzothiophene derivatives, method for preparing same and compositions containing same
09/22/2011	WO2011115378A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same
09/21/2011	CN1894217B Substituted dibenzo-azepine and benzo-diazepine derivatives useful as gamma-secretase inhibitors
09/21/2011	CN102188989A Fluidized bed catalyst and preparation method thereof
09/20/2011	US8022203 Amino derivatives of beta-homoandrostanes and beta-heteroandrostanes
09/20/2011	US8022062 6-substituted 2,3,4,5-tetrahydro-1H-benzo[d]azepines as 5-HT2C receptor agonists
09/15/2011	US20110224337 Process for preparing an n-alkyllactam with improved color quality
09/14/2011	EP2364972A1 New method for synthesising ivabradine and its addition salts
09/14/2011	CN101273017B Method of manufacturing benzoazepin compound or its salt
09/13/2011	US8017600 Imidazole compounds
09/09/2011	WO2011108251A1 Method of manufacturing epsilon-caprolactam
09/08/2011	US20110218318 Composition of Matter
09/07/2011	EP2363394A1 8-Chloro-1-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine, its salts, solvates or hydrates and its use for the treatment of CNS disorders
09/07/2011	CN102174016A Method for preparing 7-chloro-2,3,4,5-tetrahydro-1H-1-benzoazepine-2,5-diketone
09/06/2011	US8012955 N-substituted-heterocycloalkyloxybenzamide compounds and methods of use
09/01/2011	WO2011105700A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same
09/01/2011	WO2011104723A2 Acid addition salts of ivabradine and preparation thereof
09/01/2011	US20110213144 Dye, photoelectric conversion element using the same, photoelectrochemical cell, and method of producing dye
09/01/2011	US20110212943 Novel bridged cyclic compounds as histone deacetylase inhibitors
09/01/2011	US20110212920 N-Substituted Benzene Sulfonamides
08/2011
08/31/2011	CN101289426B Process for preparing restraining agent for leishmaniasis
08/30/2011	US8008479 Organic compounds
08/30/2011	US8008290 Compounds
08/30/2011	CA2531165C A method for the preparation of enantiomerically pure mirtazapine
08/30/2011	CA2440473C Metalloproteinase inhibitors

1 ... 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 ... 88